Insurance Denied Chronic Pain Management? How to Appeal Epidural, Nerve Block, and Spinal Cord Stimulator Denials

Chronic pain affects more than 51 million Americans and is one of the most common reasons people seek medical care. When oral medications alone cannot adequately manage pain, interventional procedures — epidural steroid injections, nerve blocks, radiofrequency ablation (RFA), and spinal cord stimulation (SCS) — provide evidence-based alternatives to opioids or surgery. These procedures are routinely denied by insurers, often in direct contradiction of the CDC guidelines that those same insurers cite when they limit opioid prescribing.

Why Insurers Deny Chronic Pain Management Procedures

• Epidural steroid injections denied as "not medically necessary": Insurers impose frequency limits stricter than clinical guidelines or deny when imaging doesn't show severe pathology despite severe clinical symptoms
• Radiofrequency ablation denied for lack of diagnostic block response: Insurers require a specific percentage of pain relief from diagnostic medial branch blocks — often 50–80% — before approving RFA, and deny if the threshold is not documented precisely
• Nerve blocks classified as experimental: Procedures like stellate ganglion blocks, celiac plexus blocks, or sympathetic nerve blocks may be labeled investigational for certain conditions despite substantial published evidence
• Spinal cord stimulator denied as experimental or not medically necessary: Despite FDA clearance, SCS is denied based on documented trial period criteria, prior surgical failure requirements, or psychological evaluation issues
• Frequency limits exceeded: Per-year or per-lifetime injection limits more restrictive than ASIPP guidelines
• Step therapy from oral medications required: Insurers require failure of specific oral medications before approving interventional procedures, even when those medications have already been tried

Common denial codes: CO-50 (not medically necessary), CO-96 (non-covered charge), CO-B13 (medical necessity criteria not met), and B15 (authorization not obtained).

How to Appeal a Chronic Pain Procedure Denial

Step 1: Identify the Precise Denial Reason

Determine whether you are facing a frequency limit, a step therapy requirement, a diagnostic criteria dispute (e.g., the diagnostic block response threshold), or a broad medical necessity disagreement. Each requires a different rebuttal, and conflating them in a single letter weakens every argument.

Step 2: Cite ASIPP Evidence-Based Guidelines

The American Society of Interventional Pain Physicians (ASIPP) Evidence-Based Guidelines provide the most detailed clinical framework for interventional pain procedures. ASIPP guidelines support epidural steroid injections for radicular pain from disc herniation and spinal stenosis (CPT 62321, 62323), with frequency of 3–4 injections per year per spinal region as generally appropriate. ASIPP and the American Society of Regional Anesthesia and Pain Medicine (ASRA) support RFA for chronic facet joint pain following positive medial branch blocks. For the RFA diagnostic block threshold dispute: the literature supports both 50% and 80% thresholds, and ASIPP guidelines note that a rigid percentage cutoff lacks strong evidence basis — cite this directly if your insurer is requiring 80% when you had 60% relief.

Step 3: Use the CDC 2022 Guideline to Support Interventional Procedures

The CDC's 2022 Clinical Practice Guideline for Prescribing Opioids for Pain explicitly recommends non-opioid therapies — including interventional procedures — as preferred first-line treatments for chronic pain. When an insurer denies epidurals or nerve blocks while also limiting opioids, the CDC guideline creates a powerful argument: "The 2022 CDC Clinical Practice Guideline for Prescribing Opioids recommends the interventional procedure we are requesting as an opioid-sparing alternative. Denying this procedure while restricting opioids leaves the patient with no evidence-based treatment option."

Step 4: Address Spinal Cord Stimulator Denials with Level I Evidence

For SCS appeals, the North American Neuromodulation Society (NANS) guidelines and landmark randomized controlled trials — including the PROCESS trial and SENZA-RCT — establish Level I evidence for SCS superiority over conventional medical management in failed back surgery syndrome (FBSS) and complex regional pain syndrome (CRPS). ICD-10 codes supporting SCS: M89.0x (Algoneurodystrophy/CRPS), M54.5x (Low back pain), G57.2 (femoral nerve lesion). If the SCS trial succeeded and permanent implant was denied, this is your strongest argument: the therapy has already demonstrated effectiveness in your specific case.

Step 5: Obtain a Detailed Letter from the Pain Management Specialist

This letter should include: diagnosis with ICD-10 code; all conservative and pharmacological treatments tried with documented outcomes; clinical rationale for the specific procedure; reference to ASIPP or NANS guidelines by name; and specifically why the procedure is preferable to opioids in this patient's clinical situation, invoking the CDC 2022 guideline.

Step 6: Request External Independent Review: Complete Guide" class="auto-link">External Review with a Pain Management Specialist Reviewer

Interventional pain procedures are well-supported by clinical evidence. Request external independent review and ask for a reviewer with pain management or anesthesiology expertise. External reviewers with this background frequently overturn denials that exceed clinical guideline criteria.

What to Include in Your Appeal

• Pain specialist evaluation notes: Diagnosis, functional impact documentation, and conservative treatment history
• Diagnostic procedure results: Diagnostic block response documentation for RFA cases, with specific percentage of relief noted
• ASIPP evidence-based guidelines: Available at asipp.org, with specific citation to the relevant procedure section
• CDC 2022 Clinical Practice Guideline: Documenting that interventional procedures are recommended as opioid-sparing alternatives
• NANS guidelines for SCS: Including SCS trial results if a trial was completed successfully

Fight Back With ClaimBack

Chronic pain is debilitating, and untreated pain has serious physical and mental health consequences. When your insurer denies the very procedures that the CDC recommends as opioid-sparing alternatives, the legal and clinical case for appeal is strong. ClaimBack helps you build a comprehensive, guideline-backed appeal that addresses your insurer's specific denial criteria. ClaimBack generates a professional appeal letter in 3 minutes. Start your free claim analysis → Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal